- Home
- HYFM vs XAIR Comparison
HYFM vs XAIR Comparison
Compare HYFM & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFM | XAIR |
|---|---|---|
| Founded | 1977 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2M | 10.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | HYFM | XAIR |
|---|---|---|
| Price | $1.85 | $0.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 122.8K | ★ 149.4K |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,443,000.00 | $5,802,000.00 |
| Revenue This Year | N/A | $128.45 |
| Revenue Next Year | $51.57 | $153.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $1.45 | $0.67 |
| 52 Week High | $6.89 | $10.40 |
Technical Indicators
Market Signals| Indicator | HYFM | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 43.15 |
| Support Level | $1.92 | $0.78 |
| Resistance Level | $2.30 | $0.98 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 50.60 | 69.06 |
Price Performance
Historical ComparisonAbout HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.